Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis




Benigni F, Baroni E, Zecevic M, Zvara P, Streng T, Hedlund P, Colli E, D'Ambrosio D, Andersson KE

PublisherBLACKWELL PUBLISHING

2006

BJU International

BJU INTERNATIONAL

BJU INT

97

3

617

624

8

1464-4096

DOIhttps://doi.org/10.1111/j.1464-410X.2006.05971.x



Vitamin D3 analogues may successfully be used as anti-inflammatory agents in allergen-mediated inflammatory reactions. Moreover, the modulatory effect shown on mast cell activation by the BXL628 analogue strongly supports its potential therapeutic use in a possibly mast cell-dependent disease such as human interstitial cystitis.



Last updated on 2025-14-10 at 09:56